Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia
Clinical trial NCT05929248 · UNKNOWN
Trial details
- NCT number
- NCT05929248
- Sponsor
- Guanmin Gao
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-06-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.